The DL-Methionine amino acid price outlook for Q1 2026 is soft but not collapsing. According to All About Feed's November market review, compiled with Feed Additive Prices, methionine sentiment is slightly weak in most regions while suppliers defend current levels, and buyers who have already covered Q4 are in no hurry to book Q1. Across the wider feed amino acid group, prices are mostly stable and several sit near historic lows. For a feed or premix manufacturer in Southeast Asia, that combination is a planning window rather than a signal to wait indefinitely.
What the market review actually reported
All About Feed's review covers the main feed-grade amino acids product by product. None of the figures below are DIC's; they are the review's own characterisation of the market in early November.
| Amino acid | Reported price situation | Reported contracting status |
|---|---|---|
| DL-Methionine | Slightly weak sentiment in most regions; suppliers defending current levels | Q4 contracted; buyers not yet booking Q1 |
| L-Lysine | FOB China stable for weeks at a low level; elevated in the US and Europe because of anti-dumping measures on Chinese origin | Q4 and Q1 mostly contracted |
| L-Threonine | FOB China stable for several weeks | Q4 and most of Q1 contracted |
| L-Tryptophan | At an all-time low and recently stabilised; unclear whether the bottom has been reached | Q4 and a decent share of Q1 contracted |
| L-Valine | Stable at very low levels | Q1 only partly contracted |
The review links methionine's softer tone to methionine availability and the recent decline in oil prices, and points to uncertainty over previously announced threonine capacity expansions as a factor still hanging over that market. It gives no firm forecast for any product.
Why DL-Methionine is softer than the rest of the group
Methionine is the one amino acid in the review described as weakening rather than simply flat. Two drivers are named. The first is availability: there is enough methionine on the market that suppliers are defending price rather than raising it. The second is oil. DL-Methionine is produced by chemical synthesis from petrochemical intermediates, so a fall in oil prices eases its production cost in a way that does not apply to fermentation-based amino acids such as lysine, threonine and tryptophan. That is why methionine can drift independently of the others even when the whole group looks quiet.
For buyers, the practical reading is that methionine cost is currently tied to energy markets as much as to feed demand. If oil reverses, methionine sentiment can turn before the fermentation amino acids do.
The detail most buyers will miss: lysine anti-dumping duties
The review notes that lysine prices in the United States are elevated for product of Chinese origin because of anti-dumping implications, and that in Europe the pre-announcement of upcoming anti-dumping duties has already fixed prices at a higher level. FOB China, meanwhile, has stayed low.
That gap matters in Southeast Asia for two reasons. First, when Western markets become expensive or restricted for Chinese lysine, export volume looks for other destinations, and Asia is the obvious one. That tends to keep regional offers competitive. Second, if your finished feed or premix is exported to a market applying those duties, the origin of the lysine inside it can become a documentation question for your customer. It is worth confirming now what origin declarations your export customers expect, before Q1 contracts are signed.
What this means for your line
- Feed mills and premix plants: methionine, lysine, threonine and tryptophan are the limiting amino acids in most poultry and swine diets. With Q4 already contracted across the market, the open question is Q1. Low prices reduce the cost of carrying a little more cover; they do not remove the risk of a quick turn once buyers return.
- Pet-food manufacturers: the same amino acids appear in complete-diet formulations at smaller volumes. Smaller buyers usually book later than large integrators, so watch whether Q1 availability narrows as the big contracts are placed.
- Exporters of finished feed: check the lysine origin question above before you lock supply for products shipped to the US or EU.
What to check before booking Q1
- Your cover in weeks, per amino acid. Methionine, lysine and threonine rarely move together on the same day, so one blended "amino acid cover" figure hides the real exposure.
- How much of your Q1 need is already contracted. The review says most of the market has contracted Q4 and much of Q1 for lysine, threonine and tryptophan. If you have not, you are buying from what remains.
- Oil prices. For DL-Methionine specifically, a sustained rebound in oil is an early warning that the soft tone may not last.
- Threonine capacity news. Confirmation or cancellation of announced expansions will move threonine sentiment more than demand will.
- Origin documentation. If any of your output goes to markets applying anti-dumping duties on Chinese lysine, agree origin paperwork with your supplier now.
- Grade and specification. A low market is a common time for off-specification or poorly documented material to appear. Keep the Certificate of Analysis and lot traceability requirements in every contract.
Frequently Asked Questions
Will DL-Methionine prices fall further in Q1 2026?
The market review describes methionine sentiment as slightly weak, with suppliers defending current levels, and gives no forecast. The two drivers it names are methionine availability and lower oil prices, so those are the indicators to watch rather than a single price figure.
Why is lysine more expensive in the US and Europe than in China?
According to the review, US prices for Chinese-origin lysine are elevated because of anti-dumping implications, and in Europe the pre-announcement of upcoming anti-dumping duties has fixed prices at a higher level. FOB China prices have stayed stable at a low level.
Have amino acid prices reached the bottom?
For tryptophan, the review says prices are at an all-time low and have stabilised, but it is not yet clear whether they have bottomed. Lysine, threonine and valine are described as stable at low levels.
How we grow with you
Low prices and cautious buying make it tempting to run cover down and wait. The risk is that a feed line ends up waiting on a single shipment when the market turns. DIC holds feed amino acids in stock in Thailand, offers more than one origin where specification allows, and runs Vendor-Managed Inventory programs that carry the buffer for you, so your production plan does not depend on timing the bottom. If you are planning Q1 amino acid cover, our team can review your volumes and documentation needs with you.
